The latest myeloma news
On September 20, 2024, the Food and Drug Administration approved isatuximab-irfc (Sarclisa, Sanofi-Aventis U.S. LLC)…
During Blood Cancer Awareness Month Blood Cancer UK releases its comprehensive Action Plan “Taking blood…
Multiple myeloma (MM) is a complex haematological malignancy with significant unmet needs. While conventional therapies…
On July 30, 2024, the Food and Drug Administration approved daratumumab and hyaluronidase-fihj in combination with…
A simple blood test that measures the number of lymphocytes, a type of white blood…
The 14-month median follow-up data from the pivotal Phase 1/2 LINKER-MM1 trial of linvoseltamab in…
According to a new study, adding belantamab mafodotin to pomalidomide and dexamethasone for the treatment…
A U.S. Food and Drug Administration committee voted unanimously in April to approve a new…
A study reveals persistent racial and social disparities preventing access to autoHCT in the USA,…
CAR T cell therapy has proven effective in treating various haematological cancers. However, not all…